The effect of inducing agents on the metabolism of ethidium bromide by isolated rat hepatocytes

Chemico-Biological Interactions

Volumn 123, Issue 2, 1999, Pages 105-115

  Tettey, J N A ^a   Skellern, G G ^a   Midgley, J M ^a   Grant, M H ^a   Pitt, A R ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Ethidium bromide; Hepatocytes; Inducing agents; Metabolism; N Glucuronidation

Indexed keywords

3 METHYLCHOLANTHRENE; ANTITRYPANOSOMAL AGENT; DRUG METABOLITE; ETHIDIUM BROMIDE; PHENOBARBITAL;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INCUBATION TIME; LIVER CELL; NONHUMAN; RAT; REACTION ANALYSIS;

ANIMALS; BIOTRANSFORMATION; CELL SEPARATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHIDIUM; LIVER; MALE; MASS SPECTROMETRY; METHYLCHOLANTHRENE; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRYPANOCIDAL AGENTS;

EID: 0032705574     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00127-1     Document Type: Article

References (27)

1. Borst P. Mitochondrial Nucleic Acids. Ann. Rev. Biochem. 41:1972;333-376.
2. Thomas J.C., Desrosiers M., St-Pierre Y., Lirette P., Bisaillon J.G., Beaudet R., Villemur R. Quantitative flow cytometric detection of specific microorganisms in soil samples using RNA targeted fluorescent probes and ethidium bromide. Cytometry. 27:1997;224-232.
3. Sharma R.K., Katoch K., Shivannavar C.T., Sharma V.D., Natrajan M., Bhatia A.S., Saxena N., Katoch V.M. Detection of M. leprae by gene amplification; combined ethidium-bromide staining and probe hybridization. Int. J. Lepr. Other Mycobact. Dis. 64:1996;409-416.
4. MacGregor J.T., Johnson I.J. In vitro metabolic activation of ethidium bromide and other phenanthridinium compounds: mutagenic activity in Salmonella typhimurium. Mutat. Res. 48:1977;103-108.
5. Lecointe P., Bichet N., Fraire C., Paoletti C. The hepatic metabolism of ethidium bromide to reactive mutagenic species: biochemical and structural requirements. Biochem. Pharmacol. 30:1981;601-609.
6. Tettey J.N.A., Skellern G.G., Midgley J.M., Grant M.H., Wilkinson R., Pitt A.R. Intracellular localisation and metabolism of the phenanthridinium trypanocide, ethidium bromide, by isolated rat hepatocytes. Xenobiotica. 29:1999;349-360.
7. MacGregor J.T., Clarkson T.W. Metabolism and biliary excretion of phenanthridinium salts-1, nature of the biliary metabolises. Biochem. Pharmacol. 20:1971;2833-2846.
8. Fraire C., Lecointe P., Paoletti C. Metabolism of ethidium bromide in rats. Drug Metab. Disposit. 9:1981;156-160.
9. Wang C.C. Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis. Ann. Rev. Pharmacol. Toxicol. 35:1995;93-127.
10. Holmes P.H. New approaches to the integrated control of trypanosomiasis. Vet. Parasitol. 71:1997;121-135.
11. Barrett J. Control strategies for African trypanosomiases: Their sustainability and effectiveness. Hide G., Mottram J.C., Coombs G.H., Holmes P.H. Trypanosomiasis and Leishmaniasis. 1997;347-358 CAB International, Oxon.
12. Lilienblum W., Walli A.K., Bock K.W. Differential induction of rat liver microsomal UDP-glucuronyltransferase activities by various inducing agents. Biochem. Pharmacol. 31:1982;907-913.
13. Gibson G.G., Skett P. Introduction to drug metabolism. 1994;Blackie Academic & Professional, Glasgow.
14. Li H., Dehal S.S., Kupfer D. Induction of the hepatic CYP2B and CYP3A enzymes by the proestrogenic pesticide methoxychlor and by DDT in the rat. Effects on methoxychlor metabolism. J. Biochem. Toxicol. 10:1995;51-61.
15. De Sousa G., Fontaine F., Pralavario M., Botta-Fridlund D., Letreut Y., Rahmani R. Insecticide cytotoxicity and CYPlA1/2 induction in primary human and rat hepatocyte cultures. Toxic in Vitro. 11:1997;451-457.
16. Williams B., Dransfield R., Brightwell R., Rogers D. Trypanosomiasis; where are we now? Health Policy Plan. 8:1993;85-93.
17. Moldeus P., Hogberg J., Orrenius S. Isolation and use of liver cells. Methods Enzymol. 52:1978;60-71.
18. Firth W.J., Watkins C.L., Graves D.E., Yielding L.W. Synthesis and characterization of ethidium analogs: emphasis on amino and azido substituents (1). Heterocyclic Chem. 20:1983;759-765.
19. Lavoie E.J., Adams E.A., Shigematsu A., Hoffman D. Metabolites of phenanthridine formed by rat liver homogenate. Drug Metab. Disposit. 13:1985;71-75.
20. Timbrell J.A. Principles of Biochemical Toxicology. 1991;Taylor and Francis, London.
21. Park B.K., Kittleringham N.R., Pirmohamed M., Tucker G.T. Relevance of induction of human drug metabolising enzymes: pharmacological and toxicological implications'. Br. J. Clin. Pharmacol. 41:1996;477-491.
22. Niesink R.J.M., De Vries J., Hollinger M.A. Toxicology: Principles and Applications. 1996;CRC Press, Florida.
23. Monks T.J., Hanzlik R.P., Cohen G.M., Ross D., Graham D.G. Contemporary issues in toxicology: quinone chemistry and toxicity. Toxicol. Appl. Pharmacol. 112:1992;2-16.
24. Miller E.C., Miller J.A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer. 47:1981;2327-2345.
25. Tephly T.R., Burchell B. UDP-glucuronyltranferases: a family of detoxifying enzymes. TIPS. 11:1990;276-279.
26. Mulder G.J. Glucuronidation and its role in the regulation of biological activity of drugs. Ann. Rev. Pharmacol. Toxicol. 32:1992;25-49.
27. Leach T.M., Roberts C.J. Present status of chemotherapy and chemoprophylaxis of animal trypanosomiasis in the eastern hemisphere. Pharmacol. Ther. 13:1981;91-147.